Clinical trials: Stomatitis
Minor Recurrent Aphthous Stomatitis Lesions
The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer
This is a prospective, randomized, blinded, placebo-controlled, crossover clinical trial to evaluate the efficacy of 2-DeNT oral topical powder in the treatment of recurrent aphthous stomatitis (RAS).
- Trial name
- NCT02142543
- Testing
- 2-DeNT powder
- Where
- United States
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Texas A&M University
Oral Mucositis
Oral Mucositis in Patients Undergoing Antineoplastic Chemotherapy
The purpose of this study was to: 1. To investigate the feasibility of using infrared (IR) thermometer to grade the severity of oral mucositis in patients with multiple myeloma undergoing chemotherapy. 2.
- Trial name
- Mucositis (NCT01036633)
- Testing
- Infrared Thermometer
- Volunteers
- 4 people, healthy volunteers welcome
- Sponsor
- University of Arkansas
Mucositis, Head and Neck Cancer
A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis
The specific aim of this study will be to determine the safety of TRAUMEEL S for mucositis in head and neck cancer patients undergoing radiation therapy.
- Trial name
- TRAUMEEL (NCT00584597)
- Testing
- Saline, Traumeel S
- Where
- United States
- Volunteers
- 14 people, healthy volunteers welcome
- Sponsor
- University of Oklahoma
Oral Mucositis
Hexetidine and Chlorobutanol for Lesions Due to Prostheses
Objectives: The study aimed at assessing the efficacy of a new mouthwash in treating oral lesions due to removable prostheses. Methods: The present prospective randomized clinical trial was performed on 44 patients.
- Trial name
- NCT01115049
- Testing
- chlorobutanol, hexetidine, Chlorhexidine
- Where
- Italy
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Federico II University
Acquired Immunodeficiency Syndrome, Burning Mouth Syndrome
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
This study will test the effectiveness of topical thalidomide in healing mouth sores in HIV infected patients. Oral (PO) thalidomide heals these sores at a dose of 200 mg per day.
- Conditions
- Acquired Immunodeficiency Syndrome, Burning Mouth Syndrome, HIV Infection
- Trial name
- NCT00001524
- Testing
- Thalidomide
- Where
- United States
- Volunteers
- 110 people, healthy volunteers welcome
- Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)